MARKET

CGEN

CGEN

Compugen
NASDAQ
2.260
+0.060
+2.73%
After Hours: 2.274 +0.014 +0.61% 17:33 04/02 EDT
OPEN
2.200
PREV CLOSE
2.200
HIGH
2.280
LOW
2.190
VOLUME
205.71K
TURNOVER
--
52 WEEK HIGH
2.380
52 WEEK LOW
1.130
MARKET CAP
213.69M
P/E (TTM)
6.00
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CGEN last week (0323-0327)?
Weekly Report · 4d ago
Weekly Report: what happened at CGEN last week (0316-0320)?
Weekly Report · 03/23 10:33
Weekly Report: what happened at CGEN last week (0309-0313)?
Weekly Report · 03/16 10:32
Weekly Report: what happened at CGEN last week (0302-0306)?
Weekly Report · 03/09 10:32
Truist Financial Sticks to Its Buy Rating for Compugen (CGEN)
TipRanks · 03/03 12:36
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 03/03 11:40
Compugen Earnings Call: Cash Windfall, Trials and Risks
TipRanks · 03/03 00:05
Compugen: Non-Dilutive Funding For Rilvegostomig Obtained And GS-0321 Advancement
Seeking Alpha · 03/02 19:35
More
About CGEN
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.

Webull offers Compugen Ltd (USA) stock information, including NASDAQ: CGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CGEN stock methods without spending real money on the virtual paper trading platform.